The Role of NCS1 in Immunotherapy and Prognosis of Human Cancer
Open Access
- 12 October 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (10) , 2765
Abstract
The Neural Calcium Sensor1 (NCS1) is a crucial protein that binds to Ca2+ and is believed to play a role in regulating tumor invasion and cell proliferation. However, the role of NCS1 in immune infiltration and cancer prognosis is still unknown. Our study aimed to explore the expression profile, immune infiltration pattern, prognostic value, biological function, and potential compounds targeting NCS1 using public databases. High expression of NCS1 was detected by immune histochemical staining in LIHC (Liver hepatocellular carcinoma), BRCA (Breast invasive carcinoma), KIRC (Kidney renal clear cell carcinoma), and SKCM (Skin Cutaneous Melanoma). The expression of NCS1 in cancer was determined by TCGA (The Cancer Genome Atlas Program), GTEx (The Genotype-Tissue Expression), the Kaplan–Meier plotter, GEO (Gene Expression Omnibus), GEPIA2.0 (Gene Expression Profiling Interactive Analysis 2.0), HPA (The Human Protein Atlas), UALCAN, TIMER2.0, TISIDB, Metascape, Drugbank, chEMBL, and ICSDB databases. NCS1 has genomic mutations as well as aberrant DNA methylation in multiple cancers compared to normal tissues. Also, NCS1 was significantly different in the immune microenvironment, tumor mutational burden (TMB), microsatellite instability (MSI), and immune infiltrate-associated cells in different cancers, which could be used for the typing of immune and molecular subtypes of cancer and the presence of immune checkpoint resistance in several cancers. Univariate regression analysis, multivariate regression analysis, and gene enrichment analysis to construct prognostic models revealed that NCS1 is involved in immune regulation and can be used as a prognostic biomarker for SKCM, LIHC, BRCA, COAD, and KIRC. These results provide clues from a bioinformatic perspective and highlight the importance of NCS1 in a variety of cancers.Keywords
Funding Information
- Hubei Provincial Natural Science Foundation of China (2023AFB646, 2023020201010155)
- Knowledge Innovation Program of Wuhan-Basic Research (2023AFB646, 2023020201010155)
This publication has 67 references indexed in Scilit:
- Pan-cancer patterns of somatic copy number alterationNature Genetics, 2013
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cellsNature Medicine, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perilsExpert Opinion on Therapeutic Targets, 2012
- A roadmap to generate renewable protein binders to the human proteomeNature Methods, 2011
- ORAI1-Mediated Calcium Influx in Lactation and in Breast CancerMolecular Cancer Therapeutics, 2011
- Genetic prognostic and predictive markers in colorectal cancerNature Reviews Cancer, 2009
- The functional consequences of alternative promoter use in mammalian genomesTrends in Genetics, 2008
- Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithiumJournal of Clinical Investigation, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005